HEADER RNA BINDING PROTEIN 03-NOV-06 2J98 TITLE HUMAN CORONAVIRUS 229E NON STRUCTURAL PROTEIN 9 CYS69ALA MUTANT (NSP9) COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1AB; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 3825-3933; COMPND 5 SYNONYM: PP1AB, ORF1AB POLYPROTEIN, NON STRUCTURAL PROTEIN 9 MUTANT; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REPLICASE POLYPROTEIN 1AB; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 3825-3933; COMPND 12 SYNONYM: PP1AB, ORF1AB POLYPROTEIN, NON STRUCTURAL PROTEIN 9 MUTANT; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN CORONAVIRUS 229E; SOURCE 3 ORGANISM_COMMON: HCOV 229E; SOURCE 4 ORGANISM_TAXID: 11137; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN CORONAVIRUS 229E; SOURCE 9 ORGANISM_COMMON: HCOV 229E; SOURCE 10 ORGANISM_TAXID: 11137; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SSB, HCOV, MEMBRANE, HELICASE, SARS COV, VIRAL REPLICASE, RNA KEYWDS 2 REPLICATION, ATP-BINDING, NUCLEOTIDE-BINDING, RIBOSOMAL FRAMESHIFT, KEYWDS 3 RNA-BINDING PROTEIN, RNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.PONNUSAMY,J.R.MESTERS,R.MOLL,R.HILGENFELD REVDAT 8 13-DEC-23 2J98 1 REMARK REVDAT 7 24-JUL-19 2J98 1 REMARK REVDAT 6 13-JUL-11 2J98 1 VERSN REVDAT 5 24-FEB-09 2J98 1 VERSN REVDAT 4 04-NOV-08 2J98 1 JRNL REVDAT 3 26-AUG-08 2J98 1 JRNL REMARK DBREF SEQADV REVDAT 2 11-DEC-07 2J98 1 HEADER COMPND KEYWDS ATOM REVDAT 1 27-NOV-07 2J98 0 JRNL AUTH R.PONNUSAMY,R.MOLL,T.WEIMAR,J.R.MESTERS,R.HILGENFELD JRNL TITL VARIABLE OLIGOMERIZATION MODES IN CORONAVIRUS NON-STRUCTURAL JRNL TITL 2 PROTEIN 9. JRNL REF J.MOL.BIOL. V. 383 1081 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18694760 JRNL DOI 10.1016/J.JMB.2008.07.071 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 15696 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1125 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1136 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.51 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 83 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1605 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 8 REMARK 3 SOLVENT ATOMS : 74 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 36.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.99000 REMARK 3 B22 (A**2) : -0.52000 REMARK 3 B33 (A**2) : 1.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.169 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.167 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.371 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1619 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2184 ; 1.639 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 202 ; 6.958 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 63 ;35.397 ;23.492 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 276 ;18.044 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;24.520 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 237 ; 0.121 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1205 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 707 ; 0.230 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1095 ; 0.319 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 82 ; 0.165 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 47 ; 0.279 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.382 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1028 ; 1.070 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1614 ; 1.735 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 681 ; 2.921 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 570 ; 4.153 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 108 REMARK 3 ORIGIN FOR THE GROUP (A): 5.3486 18.4814 147.0995 REMARK 3 T TENSOR REMARK 3 T11: -0.0648 T22: -0.0764 REMARK 3 T33: -0.0729 T12: 0.0033 REMARK 3 T13: -0.0188 T23: 0.0118 REMARK 3 L TENSOR REMARK 3 L11: 4.1849 L22: 2.7528 REMARK 3 L33: 1.1411 L12: -0.3797 REMARK 3 L13: -0.0252 L23: 0.1496 REMARK 3 S TENSOR REMARK 3 S11: -0.0208 S12: -0.1631 S13: -0.1928 REMARK 3 S21: 0.2507 S22: 0.0203 S23: 0.0170 REMARK 3 S31: 0.1485 S32: 0.0353 S33: 0.0005 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 6 B 106 REMARK 3 ORIGIN FOR THE GROUP (A): 6.3227 22.5195 120.6709 REMARK 3 T TENSOR REMARK 3 T11: -0.0594 T22: -0.0760 REMARK 3 T33: -0.0775 T12: 0.0100 REMARK 3 T13: -0.0251 T23: -0.0406 REMARK 3 L TENSOR REMARK 3 L11: 3.0574 L22: 2.5515 REMARK 3 L33: 1.4018 L12: 0.0108 REMARK 3 L13: -0.5644 L23: -0.4270 REMARK 3 S TENSOR REMARK 3 S11: 0.0326 S12: -0.0273 S13: 0.0621 REMARK 3 S21: -0.1991 S22: -0.0378 S23: 0.0661 REMARK 3 S31: -0.1426 S32: -0.0340 S33: 0.0052 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS.RESIDUES 1,2 AND 107,108 FROM CHAIN A, RESIDUES 1-4 REMARK 3 FROM CHAIN B ARE DISORDERED.CHAIN A RESIDUES 55REMARK REMARK 3 OCCUPANCIES SET TO ZERO. VIZIER.VIRAL ENZYMES INVOLVED IN REMARK 3 REPLICATION. REMARK 4 REMARK 4 2J98 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1290030314. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL SUITE REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17889 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.070 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1QZ8 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA ACETATE PH 4.6 30% PEG MME REMARK 280 2000, PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 13.19800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.65450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.68850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.65450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 13.19800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.68850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 3893 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 3893 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 1 REMARK 465 ASN A 2 REMARK 465 GLN A 109 REMARK 465 ASN B 1 REMARK 465 ASN B 2 REMARK 465 GLU B 3 REMARK 465 ILE B 4 REMARK 465 ARG B 107 REMARK 465 LEU B 108 REMARK 465 GLN B 109 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLU A 55 REMARK 475 HIS A 56 REMARK 475 ASP A 57 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2027 O HOH B 2029 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2007 O HOH B 2035 4557 1.96 REMARK 500 OE1 GLU A 55 OE1 GLU B 55 3547 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 32 62.66 -116.44 REMARK 500 HIS A 56 147.54 178.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS A 56 ASP A 57 -95.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TRP A 54 15.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DTT A1109 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P9S RELATED DB: PDB REMARK 900 CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE : BASIS FORDESIGN OF REMARK 900 ANTI-SARS DRUGS REMARK 900 RELATED ID: 2J97 RELATED DB: PDB REMARK 900 HUMAN CORONAVIRUS 229E NON STRUCTURAL PROTEIN 9 (NSP9) DBREF 2J98 A 1 109 UNP P0C6U2 R1A_CVH22 3825 3933 DBREF 2J98 B 1 109 UNP P0C6U2 R1A_CVH22 3825 3933 SEQADV 2J98 ALA A 69 UNP P0C6U2 CYS 3893 ENGINEERED MUTATION SEQADV 2J98 LYS B 5 UNP P0C6U2 MET 3829 CONFLICT SEQADV 2J98 ALA B 69 UNP P0C6U2 CYS 3893 ENGINEERED MUTATION SEQRES 1 A 109 ASN ASN GLU ILE MET PRO GLY LYS MET LYS VAL LYS ALA SEQRES 2 A 109 THR LYS GLY GLU GLY ASP GLY GLY ILE THR SER GLU GLY SEQRES 3 A 109 ASN ALA LEU TYR ASN ASN GLU GLY GLY ARG ALA PHE MET SEQRES 4 A 109 TYR ALA TYR VAL THR THR LYS PRO GLY MET LYS TYR VAL SEQRES 5 A 109 LYS TRP GLU HIS ASP SER GLY VAL VAL THR VAL GLU LEU SEQRES 6 A 109 GLU PRO PRO ALA ARG PHE VAL ILE ASP THR PRO THR GLY SEQRES 7 A 109 PRO GLN ILE LYS TYR LEU TYR PHE VAL LYS ASN LEU ASN SEQRES 8 A 109 ASN LEU ARG ARG GLY ALA VAL LEU GLY TYR ILE GLY ALA SEQRES 9 A 109 THR VAL ARG LEU GLN SEQRES 1 B 109 ASN ASN GLU ILE LYS PRO GLY LYS MET LYS VAL LYS ALA SEQRES 2 B 109 THR LYS GLY GLU GLY ASP GLY GLY ILE THR SER GLU GLY SEQRES 3 B 109 ASN ALA LEU TYR ASN ASN GLU GLY GLY ARG ALA PHE MET SEQRES 4 B 109 TYR ALA TYR VAL THR THR LYS PRO GLY MET LYS TYR VAL SEQRES 5 B 109 LYS TRP GLU HIS ASP SER GLY VAL VAL THR VAL GLU LEU SEQRES 6 B 109 GLU PRO PRO ALA ARG PHE VAL ILE ASP THR PRO THR GLY SEQRES 7 B 109 PRO GLN ILE LYS TYR LEU TYR PHE VAL LYS ASN LEU ASN SEQRES 8 B 109 ASN LEU ARG ARG GLY ALA VAL LEU GLY TYR ILE GLY ALA SEQRES 9 B 109 THR VAL ARG LEU GLN HET DTT A1109 8 HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 3 DTT C4 H10 O2 S2 FORMUL 4 HOH *74(H2 O) HELIX 1 1 ILE A 4 LYS A 8 5 5 HELIX 2 2 ASN A 91 VAL A 106 1 16 HELIX 3 3 ASN B 91 VAL B 106 1 16 SHEET 1 AA 7 VAL A 60 GLU A 64 0 SHEET 2 AA 7 TYR A 51 GLU A 55 -1 O VAL A 52 N VAL A 63 SHEET 3 AA 7 LYS A 10 GLU A 17 -1 O LYS A 15 N LYS A 53 SHEET 4 AA 7 THR A 23 ASN A 31 -1 O SER A 24 N GLY A 16 SHEET 5 AA 7 PHE A 38 THR A 44 -1 O PHE A 38 N ASN A 31 SHEET 6 AA 7 GLY A 78 PHE A 86 -1 O TYR A 83 N THR A 44 SHEET 7 AA 7 ALA A 69 THR A 75 -1 O ALA A 69 N LEU A 84 SHEET 1 BA 7 VAL B 60 GLU B 64 0 SHEET 2 BA 7 MET B 49 GLU B 55 -1 O VAL B 52 N VAL B 63 SHEET 3 BA 7 MET B 9 GLY B 18 -1 O GLU B 17 N LYS B 50 SHEET 4 BA 7 THR B 23 ASN B 32 -1 O SER B 24 N GLY B 16 SHEET 5 BA 7 ALA B 37 THR B 44 -1 O PHE B 38 N ASN B 31 SHEET 6 BA 7 GLN B 80 PHE B 86 -1 O TYR B 83 N THR B 44 SHEET 7 BA 7 ALA B 69 ILE B 73 -1 O ALA B 69 N LEU B 84 SITE 1 AC1 4 ASN A 27 VAL A 43 LYS A 82 HOH A2028 CRYST1 26.396 61.377 107.309 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.037885 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016293 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009319 0.00000 MTRIX1 1 0.997500 -0.070300 -0.000359 0.82730 1 MTRIX2 1 -0.069910 -0.991400 -0.110200 53.99000 1 MTRIX3 1 0.007392 0.110000 -0.993900 265.30000 1